- Meningitis remains an important cause of morbidity and mortality among children >5 years of age and is especially prevalent in developing countries. Effective routine immunization against Hib, pneumococcus and serogroupC meningococcus has had a significant impact on both invasive disease and carriage caused by these encapsulated bacteria. The major challenge in prevention of meningitis remains the delivery of vaccines worldwide, especially to resource-poor regions with the greatest disease burden.
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- Copyright holder:
- S. Segal & A. J. Pollard
- Copyright date:
- The full-text of this article is not currently available in ORA.[The definitive publisher-authenticated version is available online at: http://bmb.oxfordjournals.org/content/72/1/65.full].
Vaccines against bacterial meningitis
If you are the owner of this record, you can report an update to it here: Report update to this record